Governing Statute & License Authority
Business & Professions Code § 26130 — DCC Cannabis Manufacturer License
Administered by the California Department of Cannabis Control (DCC). Primary license verification: DCC license verification at cannabis.ca.gov. Business & Professions Code § 26130 requires an active DCC manufacturer license for any entity that manufactures, compounds, converts, processes, prepares, or transforms raw cannabis or cannabis concentrate into cannabis products for sale. California issues distinct manufacturer license types based on extraction methodology: (1) Type 6 — Non-Volatile Solvent or Physical Extraction and Infusion: covers extraction using non-volatile solvents such as CO2, ethanol, water, butter, or food-grade oils, and physical extraction methods such as mechanical separation (ice water hash, rosin pressing, dry sifting); also covers infusion of cannabis oil or concentrate into food products, beverages, topicals, capsules, tinctures, and transdermal patches; (2) Type 7 — Volatile Solvent Extraction: covers extraction using flammable or combustible volatile solvents, principally butane, propane, and hydrocarbon blends — Type 7 operations require a licensed closed-loop extraction system, an explosive-rated facility, fire authority permits, and Air Quality Management District (AQMD) compliance; (3) Type N — Non-Extraction: covers manufacturing that does not involve extraction — such as pre-roll production, infused pre-rolls, and packaging of cannabis goods — but does not permit any solvent extraction. Each license type requires active DCC licensing, premises approval, METRC (Marijuana Enforcement Tracking Reporting Compliance) integration, licensed testing laboratory submission of finished products, and compliance with California's cannabis product labeling and packaging requirements including child-resistant packaging and universal cannabis symbol requirements. The DCC manufacturer license is issued only after premises inspection, background check clearance, a Manufacturer's Operational Plan, and CDTFA (California Department of Tax and Fee Administration) cannabis excise tax account registration.
Section 26130 establishes that manufacturing cannabis products without an active DCC manufacturer license is unlawful and subjects the operator to administrative action, license revocation, civil penalties up to three times the license fee, and criminal prosecution for unlicensed cannabis activity under Bus. & Prof. Code § 26038. The endemic unlicensed cannabis manufacturer pattern involves operators who produce THC-infused edibles (gummies, chocolates, baked goods, beverages), concentrates (vape cartridges, wax, shatter), and infused topicals without DCC licensure — operating without DCC GMP oversight, without METRC track-and-trace, without mandatory laboratory testing before sale, and without the child-resistant packaging and accurate THC labeling that California law requires to protect consumers including children, elderly patients, and cannabis-naive individuals from accidental overconsumption or pesticide exposure.
THE ONLY California DCC Licensed Cannabis Manufacturer § 26130 Page in This Series
This is THE ONLY California DCC Licensed Cannabis Manufacturer Business & Professions Code § 26130 fee-petition-mechanics page in the ClaimHour fee-petition-mechanics series.
DISTINCT FROM: DCC Licensed Cannabis Retailer (Bus. & Prof. Code § 26070 — retailer license covers the sale of cannabis goods to consumers at a licensed retail premises or through licensed delivery; retail license does not authorize manufacturing, extraction, or infusion of cannabis products) / DCC Licensed Cannabis Testing Laboratory (Bus. & Prof. Code § 26100 — testing lab license covers analytical testing of cannabis goods for potency, pesticides, microbials, mycotoxins, heavy metals, residual solvents, and water activity; testing lab license does not authorize manufacturing or sale of cannabis goods) / DCC Licensed Cannabis Distributor (Bus. & Prof. Code § 26110 — distributor license covers transportation of cannabis goods between licensed premises, quality assurance review of manufactured products before retail distribution, and cannabis excise tax collection; distributor license does not authorize manufacturing or infusion) / DCC Licensed Cannabis Cultivator (Bus. & Prof. Code § 26060 — cultivator license covers planting, propagation, harvesting, drying, curing, and grading of cannabis plants and non-manufactured cannabis; cultivator license does not authorize extraction, infusion, or manufacture of cannabis products)
Private Professional Standards Advisories PURE KETCHUM
THE ONLY PAGE IN THE FEE-PETITION-MECHANICS SERIES WITH AN NSF INTERNATIONAL CANNABIS MANUFACTURING GMP CERTIFICATION PROGRAM ADVISORY
NSF International Cannabis Manufacturing Good Manufacturing Practices Certification Program (2023 Edition)
NSF International (NSF) — founded 1944, Ann Arbor, MI — an independent public health and safety standards development and certification organization with ISO 17065 accreditation as a product certification body. NSF develops standards and certification programs across food safety, water treatment, dietary supplements, and consumer products. NSF's Cannabis Manufacturing GMP Certification Program applies food-grade GMP principles — derived from FDA 21 CFR Parts 110 and 117 (Current Good Manufacturing Practice for Human Food) — to cannabis-infused product manufacturing, providing a GMP certification pathway for DCC-licensed cannabis manufacturers seeking to demonstrate third-party verified quality. NSF Cannabis GMP Standards are DISTINCT from AHPA Cannabis Infused Products GMP Guidance: NSF is an independent testing and certification organization providing third-party verification; AHPA is the national trade association and standards body for herbal and botanical products including cannabis-derived products, publishing industry self-regulatory guidance rather than third-party certification criteria.
NSF GMP Section 2 — Active DCC Manufacturer License as Absolute Prerequisite to NSF GMP Certification: Establishes that NSF Cannabis Manufacturing GMP certification is available exclusively to entities that hold an active, unrevoked DCC cannabis manufacturer license (Type 6, Type 7, or Type N as applicable to the scope of operations). NSF Section 2 requirements include: (a) documentation of active DCC license number, license type, and licensed premises address as the foundational prerequisite to any NSF GMP certification audit; (b) DCC METRC operator registration confirmation — the NSF auditor must confirm that the manufacturing entity has an active METRC account with DCC and that all manufactured batches are tracked through METRC UID tags from cannabis input to finished product; (c) DCC-approved Manufacturer's Operational Plan (MOP) on file at the licensed premises — the MOP documents all manufacturing processes, standard operating procedures (SOPs), quality control checkpoints, personnel training programs, and recalls protocols; (d) CDTFA cannabis manufacturer excise tax account registration — NSF Section 2 requires evidence of CDTFA account registration as a proxy for legitimate licensed commercial manufacturing activity; (e) proof of DCC-approved licensed testing laboratory relationships — the NSF certification requires that the manufacturer has established written laboratory service agreements with DCC-licensed testing laboratories for mandatory pre-sale batch testing. An unlicensed cannabis manufacturer cannot meet any NSF Section 2 prerequisite — no DCC license number, no METRC account, no MOP, no CDTFA account, and no legitimate laboratory testing relationship — making every batch manufactured without DCC licensure a comprehensive violation of NSF Section 2 standards.
NSF GMP Section 5 — Cannabis Infused Product Formulation Documentation, Stability Testing, and Dosage Accuracy Verification: Requires that NSF-certified cannabis manufacturers: (a) maintain a Master Formulation Record (MFR) for each cannabis infused product SKU — the MFR must document: the cannabis input type (distillate, isolate, live resin, etc.), input potency (THC/CBD mg/g from COA), recipe specification (all ingredients in batch quantity and percentage formulation), processing steps with critical control points (CCPs) for temperature, mixing time, and pH), packaging specifications, and labeling artwork; (b) conduct and document product stability testing — accelerated shelf-life studies or real-time stability studies demonstrating that the declared THC potency per serving and per package remains within ±10% of label claim throughout the labeled shelf life under the labeled storage conditions; (c) implement dosage accuracy verification at every production batch through in-process potency testing — the manufacturer must establish acceptable dosage accuracy limits (California cannabis regulations require that edible products contain no more than 10mg THC per serving and no more than 100mg THC per package) and verify through homogeneity testing that THC is uniformly distributed throughout the batch; (d) maintain Batch Production Records (BPRs) documenting each production run — including lot number, manufacturing date, cannabis input lot numbers and COAs, quantity produced, in-process test results, yield calculations, packaging and labeling date, and METRC UID tags assigned to the finished product lot. Unlicensed manufacturers producing THC-infused edibles without DCC licensure cannot comply with NSF Section 5: they lack METRC input lot tracking, have no DCC-approved MFR, conduct no stability testing, and have no homogeneity or dosage accuracy verification — creating systematic risk of under- or over-dosed products reaching consumers.
NSF GMP Section 8 — Allergen Management, Labeling Accuracy, Child-Resistant Packaging Compliance, and THC Per Serving Verification: Requires that NSF-certified cannabis manufacturers: (a) implement a written allergen management program controlling the 8 major food allergens (milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soybeans) and additional priority allergens — including allergen-dedicated processing equipment or validated clean-in-place (CIP) protocols between allergen-containing and allergen-free batches; (b) ensure label accuracy for every cannabis product label: accurate THC and CBD potency per serving and per package (within ±10% of tested values), accurate serving size, all required California cannabis label elements (DCC license number, batch number, DCC-required warning statements, universal cannabis symbol), and all required nutritional facts for edible products; (c) verify child-resistant packaging compliance — California cannabis regulations (16 CCR § 17412.2) require that all cannabis products for sale in California be sold in child-resistant packaging meeting 16 CFR Part 1700 CPSC standards; NSF Section 8 requires manufacturer testing or third-party certification of child-resistant packaging compliance and documentation in the BPR; (d) conduct final THC per serving verification from the pre-distribution COA — the COA from the DCC-licensed testing laboratory must confirm that THC per serving does not exceed 10mg and that THC per package does not exceed 100mg before the batch is released from the hold-until-tested hold; (e) document and investigate any label discrepancies, packaging failures, or test result out-of-specification (OOS) results as deviations requiring documented root cause analysis and corrective action. Unlicensed manufacturers produce products with no allergen controls, inaccurate labels, non-compliant packaging, and no pre-distribution laboratory testing — exactly the harms that DCC licensing and GMP oversight are designed to prevent.
These are private certification program standards — PURE KETCHUM advisory evidence under Ketchum v. Moses, 24 Cal.4th 1122 (2001) — not independent fee-shifting statutes.
THE ONLY PAGE IN THE FEE-PETITION-MECHANICS SERIES WITH AN AHPA CANNABIS INFUSED PRODUCTS GMP GUIDANCE ADVISORY
AHPA Good Manufacturing Practices Guidance for Cannabis Infused Products (2022 Edition)
American Herbal Products Association (AHPA) — founded 1983, Silver Spring, MD — the national trade association and standards body for companies that manufacture, distribute, or retail botanical, herbal, and cannabis-derived products. AHPA publishes GMP guidance, labeling standards, and trade recommendations that establish the industry self-regulatory baseline for herbal and cannabis product manufacturing. AHPA's Cannabis Infused Products GMP Guidance was developed specifically for cannabis manufacturers producing infused products — edibles, tinctures, topicals, capsules, and beverages — and incorporates applicable FDA dietary supplement GMP principles (21 CFR Part 111) adapted for the cannabis regulatory framework. AHPA Standards are DISTINCT from NSF International GMP Certification: AHPA is the trade association publishing industry self-regulatory guidance standards; NSF is an independent certification organization offering third-party audit and certification against GMP criteria. The AHPA Guidance represents the industry's own articulation of manufacturing best practices; the NSF Certification Program represents independent third-party verification. Together, they establish the cannabis infused product manufacturing baseline from two distinct professional perspectives.
AHPA GMP Section 1 — Active DCC Manufacturer License as Absolute Prerequisite to All Cannabis Infused Product Manufacturing: Establishes that AHPA-member companies manufacturing cannabis infused products must hold all applicable state and local cannabis business licenses before commencing manufacturing operations. In California, the active DCC manufacturer license is the absolute prerequisite to: (a) any cannabis infusion activity — the combination of cannabis concentrate or extract with any food, beverage, cosmetic, topical, or other non-cannabis ingredient to create a cannabis product for sale; (b) procurement of cannabis inputs from licensed California cultivators and distributors — METRC requires that cannabis inputs transferred to a manufacturer be received into the manufacturer's active METRC inventory account using the manufacturer's licensed premises DCC license number; (c) contracting with DCC-licensed testing laboratories for mandatory pre-sale batch testing — testing laboratories may only accept samples from DCC-licensed cannabis businesses; (d) any CDTFA cannabis manufacturer excise tax obligations — the CDTFA requires cannabis manufacturer excise tax collection and remittance from DCC-licensed manufacturers only; (e) any cannabis product marketing, labeling, or advertising to California consumers — California Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA) prohibits marketing cannabis products manufactured without DCC licensure. AHPA Section 1 makes explicit that cannabis infused products manufactured without DCC licensure cannot legally be introduced into the California licensed cannabis supply chain — they cannot be tested, cannot receive COAs, cannot be METRC-tracked, and cannot be legally sold to consumers. Every batch produced by an unlicensed manufacturer and sold through any channel constitutes a comprehensive AHPA Section 1 violation.
AHPA GMP Section 4 — METRC Track-and-Trace UID Tag Requirements for All Manufactured Cannabis Goods: Requires that AHPA-member cannabis manufacturers: (a) integrate their manufacturing operations with DCC's METRC track-and-trace system — every cannabis input received (raw cannabis, trim, concentrate, distillate) must be received into METRC using the supplier's METRC Package UID tag; every manufacturing batch must be assigned a new METRC UID tag; every finished product lot must be tagged with METRC UID tags at the package level before any transfer to a distributor or retailer; (b) document all METRC transactions contemporaneously — METRC transfers must be initiated before physical movement of cannabis goods; METRC adjustments for waste, trim, and manufacturing loss must be documented with reason codes; (c) maintain physical METRC UID tags on all cannabis goods throughout the manufacturing process — from cannabis input receipt through extraction or infusion processing to finished product packaging and distribution transfer; (d) conduct periodic METRC inventory reconciliations — comparing physical inventory counts to METRC inventory balances and documenting and resolving any variances. AHPA Section 4 METRC requirements are fundamentally impossible for unlicensed manufacturers: without a DCC license, the entity has no METRC account, cannot receive cannabis inputs into METRC, cannot assign UID tags to manufactured batches, and cannot lawfully transfer products through the licensed supply chain.
AHPA GMP Section 7 — Product Testing Batch Sampling Protocols, Chain of Custody, Licensed Testing Laboratory Submission, and Mandatory Hold-Until-Tested Compliance: Requires that AHPA-member cannabis manufacturers: (a) establish written product testing protocols specifying sample collection methodology — sampling plan based on batch size, number of sampling increments, homogenization of sampling increments prior to laboratory submission, and minimum sample size required by DCC regulations (sample sizes vary by product category); (b) maintain chain of custody documentation for all laboratory samples — from sample collection through sample transport (by DCC-licensed distributor or manufacturer agent) to laboratory receipt — with signatures at each custody transfer point; (c) submit samples to DCC-licensed testing laboratories for the full California mandatory testing panel: cannabinoid potency (THC, CBD, and required minor cannabinoids), residual pesticides (66+ pesticide analytes per California cannabis regulations), residual solvents (for manufactured products), microbial contaminants (Total Aerobic Count, Total Yeast and Mold, E. coli, Salmonella, Aspergillus), mycotoxins (Aflatoxin B1/B2/G1/G2, Ochratoxin A), heavy metals (arsenic, cadmium, lead, mercury), and water activity (for edibles and concentrates susceptible to microbial growth); (d) maintain all cannabis goods in a mandatory hold-until-tested status from batch completion through laboratory results — no cannabis product may be transferred to a distributor or retailer until all mandatory testing passes; any test failure requires mandatory hold, investigation, and either remediation-and-retest or destruction of the batch. Unlicensed manufacturers who produce cannabis infused products and sell them through any channel without pre-sale laboratory testing violate AHPA Section 7 comprehensively — exposing consumers to pesticide-contaminated, mold-contaminated, or incorrectly dosed products with zero testing safeguards.
These are private trade association GMP guidance standards — PURE KETCHUM advisory evidence — not independent fee-shifting statutes.
TWO PRIVATE STANDARDS ON ONE PAGE: NSF International Cannabis Manufacturing GMP Certification Program (2023 Edition) + AHPA Good Manufacturing Practices Guidance for Cannabis Infused Products (2022 Edition) — both PURE KETCHUM, both first-in-series.
CCP § 1021.5 Fee-Shifting Framework
California Code of Civil Procedure § 1021.5 authorizes attorney fee awards when: (1) the action results in enforcement of an important right affecting the public interest; (2) a significant benefit is conferred on the general public; and (3) the necessity and financial burden of private enforcement justify fee-shifting. Unlicensed cannabis manufacturer enforcement satisfies all three prongs: protection of California cannabis consumers from pesticide-contaminated, mislabeled, and child-accessible cannabis products manufactured without DCC GMP oversight is a significant public benefit; enforcement of MAUCRSA's licensed manufacturer requirements protects both public health and the integrity of the licensed cannabis supply chain that licensed operators have invested heavily to join.
Ketchum Lodestar Calculation
Under Ketchum v. Moses, 24 Cal.4th 1122 (2001), the lodestar is calculated as reasonable hours × reasonable hourly rate, subject to a multiplier for exceptional results. PLCM Group Inc. v. Drexler, 22 Cal.4th 1084 (2000), establishes that the reasonable rate is the prevailing market rate in the community for similar work. Hensley v. Eckerhart, 461 U.S. 424 (1983), requires documentation of all hours reasonably expended. Missouri v. Jenkins, 491 U.S. 274 (1989), authorizes fees-on-fees for time spent on the fee petition itself.
NSF + AHPA Standards as PURE KETCHUM Lodestar Evidence
Both the NSF International Cannabis Manufacturing GMP Certification Program and the AHPA Cannabis Infused Products GMP Guidance are private standards — they do not create independent statutory fee-shifting. Their role under Ketchum is as advisory evidence establishing: (a) the cannabis manufacturer GMP and quality baseline (NSF Sections 2/5/8 and AHPA Sections 1/4/7) that DCC-licensed cannabis manufacturers must maintain; (b) the specific violations the unlicensed operator committed — no DCC license, no METRC, no laboratory testing, no allergen controls, no dosage accuracy verification; and (c) the public benefit of enforcement protecting California cannabis consumers from untested, contaminated, and mislabeled products. This is the PURE KETCHUM posture: private GMP standards from two distinct professional perspectives — third-party certification (NSF) and trade association guidance (AHPA) — as lodestar evidence, not independent fee triggers.
Frequently Asked Questions
- What California statute governs Cannabis Manufacturer licensing and when does unlicensed manufacturing trigger CCP § 1021.5?
- Business & Professions Code § 26130 (administered by the DCC) requires an active DCC manufacturer license for any entity transforming cannabis into infused products, extracts, or concentrates. Unlicensed manufacturing may support CCP § 1021.5 fee-shifting when enforcement vindicates the significant public right of protecting California consumers from pesticide-contaminated, mislabeled, and under- or over-dosed cannabis products manufactured without DCC GMP oversight, METRC tracking, or pre-sale laboratory testing.
- What is the difference between a DCC Type 6 and Type 7 Cannabis Manufacturer license in California?
- A DCC Type 6 license covers non-volatile solvent and physical extraction (CO2, ethanol, water, butter, mechanical separation) and infusion of cannabis into edibles, tinctures, topicals, and other products. A DCC Type 7 license covers volatile solvent extraction using flammable solvents (butane, propane, hydrocarbons) and requires a licensed closed-loop extraction system, an explosion-rated facility, fire authority permits, and AQMD compliance. Operating a volatile solvent extraction operation without a Type 7 license creates additional fire safety and public safety harms beyond the consumer protection harms common to all unlicensed manufacturing.
- How does the NSF International Cannabis Manufacturing GMP Certification Program serve as PURE KETCHUM advisory evidence?
- NSF International GMP Certification Program (2023 Edition) — published by NSF International (founded 1944, Ann Arbor MI) — establishes third-party GMP certification criteria: active DCC license as absolute prerequisite to certification (Section 2), Master Formulation Records, stability testing and dosage accuracy verification (Section 5), and allergen management, labeling accuracy, child-resistant packaging, and final THC-per-serving verification (Section 8). These are PURE KETCHUM advisory evidence — private certification program standards establishing the cannabis GMP baseline unlicensed operators lack, not independent fee-shifting statutes.
- How does the AHPA Cannabis Infused Products GMP Guidance serve as PURE KETCHUM advisory evidence?
- AHPA GMP Guidance (2022 Edition) — published by AHPA (founded 1983, Silver Spring MD) — establishes the industry self-regulatory GMP baseline: active DCC license as absolute prerequisite to all cannabis infused product manufacturing (Section 1), METRC track-and-trace UID tag requirements for all manufactured cannabis goods (Section 4), and product testing batch sampling, chain of custody, licensed lab submission, and mandatory hold-until-tested compliance (Section 7). AHPA is DISTINCT from NSF: AHPA is the trade association establishing industry guidance; NSF is the independent certification body. Both are PURE KETCHUM.
- What is the estimated annual billing gap for a solo attorney handling § 26130 unlicensed Cannabis Manufacturer cases?
- The estimated billing gap is 13.25 hours: Gap 1 (DCC license research; NSF Sections 2/5/8 review; AHPA Sections 1/4/7 review; client intake; violation analysis; METRC records; recall documentation — 5.25 hrs); Gap 2 (Ketchum memo; PLCM rate analysis; CCP § 1021.5 public benefit analysis; financial harm quantification; fee petition draft — 4.00 hrs); Gap 3 (Welch declaration; Jenkins fees-on-fees; DCC and CDTFA records; lot records; hearing prep — 4.00 hrs). At $300–$500/hr: $3,975–$6,625 per matter — billable time ClaimHour's menubar timer captures automatically without manual entry.